US · Healthcare · Medical Care Facilities
EPS came in at 0.24 against a street estimate of 0.24 — a beat of 0.0%.
Analysts rate Guardian Pharmacy Services, Inc. a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $49.86.
CONFIDENT Guardian raised FY26 guidance after strong H1 execution. Revenue grew 2% reported (low-double-digits organic), adjusted EBITDA +23%. IRA pricing headwinds largely mitigated through operational discipline and PBM contracts. Q2 2026 No specific regional performance data disclosed. Analysts pressed on IRA phasing (2027 vs. 2026), ramp economics of new pharmacies, and regional structure impact. Management confirmed ~4-year integration path, emphasized payer education on clinical value, and noted early falls program success with limited sample size. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| FMR Inc | 5.12% |
| Wellington Management Company LLP | 2.73% |
| BlackRock Inc | 2.49% |
| Vanguard Capital Management, LLC | 2.18% |
| Woodline Partners LP | 2.06% |
| Valiant Capital Management LP | 1.87% |
| T. Rowe Price Investment Management,Inc. | 1.76% |
| Boston Partners Global Investors, Inc | 1.55% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • For the three months ended September 30, 2026, revenue was $371,070, compared with $377,427 in the prior-year quarter. • Gross pr | 2026-11-05 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter revenue was $371.1 million, down 2% year-over-year, including pricing decreases from the IRA. • Net income was $19. | 2026-11-05 |
| Company announcement · Q3 2026 GUARDIAN PHARMACY SERVICES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Company will have 63,320,300 shares of Class A common stock outstanding following | 2026-09-10 |
| Quarterly report · Q2 2026 GUARDIAN PHARMACY SERVICES, INC. — 10-Q SUMMARY (Q2 2026) --- HEADLINE NUMBERS • Q2 2026 Revenue: $351.8 million (vs. $344.3 million in Q2 2025) — | 2026-08-06 |
| Results announced · Q3 2026 GUARDIAN PHARMACY SERVICES – Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $351.8 million, up 2% year-over-year (underlying business | 2026-08-06 |
| Board / officer change · Q2 2026 GUARDIAN PHARMACY SERVICES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Report date: June 22, 2026 • Company: Guardian Pharmacy Services, Inc. (ticker: GR | 2026-06-22 |
| Material agreement · Q2 2026 GUARDIAN PHARMACY SERVICES, INC. — 8-K SUMMARY HEADLINE NUMBERS • Loan maturity extended: Revolving loan commitments maturity date extended from Apr | 2026-05-28 |
| Shareholder vote results · Q2 2026 GUARDIAN PHARMACY SERVICES, INC. – 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held May 5, 2026 • Total shares voted: approximately 55.17 million | 2026-05-07 |
Readable in the app.
| Announcement | Date |
|---|---|
| Entered into stock purchase agreements with certain shareholders Guardian Pharmacy Services (ticker: GRDN) announced a stock repurchase program and completed a public offering on March 18-20, 2026. The company entered into agreements to buy back up to 1.8 | 2026-03-23 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Guardian Pharmacy Services, Inc. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.